Radiomics is a rapidly evolving discipline in scientific research on prognostic and predictive factors for treatment response. Many cancers (prostate, lung, head and neck and breast) are currently being studied in monocentric and cooperative research projects. With this in mind, this event aims to provide an update on the recent applications of radiomics in the field of personalized treatments, with particular regard to its integration with photon and proton radiotherapy and medical oncology treatments.

CME Provider

Istituto Europeo di Oncologia S.r.l.
CME Provider (n. 207) e Segreteria Scientifica

With the Endorsement of

The webinar is fully funded by Associazione Italiana per la Ricerca sul Cancro (AIRC), project IG-14300 “Carbon ions boost followed by pelvic photon intensity modulated radiotherapy for high-risk prostate cancer”, registered at (NCT02672449), approved by IEO R86/14-IEO 98.

Organising Secretariat

MZ Congressi S.r.l.
Tel: 02 66802323 3421863400